Loading…

C/EBPβ regulates dexamethasone-induced muscle cell atrophy and expression of atrogin-1 and MuRF1

Muscle wasting in catabolic patients is in part mediated by glucocorticoids and is associated with increased expression and activity of the transcription factor C/EBPβ. It is not known, however, if C/EBPβ is causally linked to glucocorticoid‐induced muscle atrophy. We used dexamethasone‐treated L6 m...

Full description

Saved in:
Bibliographic Details
Published in:Journal of cellular biochemistry 2011-07, Vol.112 (7), p.1737-1748
Main Authors: Gonnella, Patricia, Alamdari, Nima, Tizio, Steven, Aversa, Zaira, Petkova, Victoria, Hasselgren, Per-Olof
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Muscle wasting in catabolic patients is in part mediated by glucocorticoids and is associated with increased expression and activity of the transcription factor C/EBPβ. It is not known, however, if C/EBPβ is causally linked to glucocorticoid‐induced muscle atrophy. We used dexamethasone‐treated L6 myoblasts and myotubes to test the role of C/EBPβ in glucocorticoid‐induced expression of the muscle‐specific ubiquitin ligases atrogin‐1 and MuRF1, protein degradation, and muscle atrophy by transfecting cells with C/EBPβ siRNA. In myoblasts, silencing C/EBPβ expression with siRNA inhibited dexamethasone‐induced increase in protein degradation, atrogin‐1 and MuRF1 expression, and muscle cell atrophy. Similar effects of C/EBPβ siRNA were seen in myotubes except that the dexamethasone‐induced increase in MuRF1 expression was not affected by C/EBPβ siRNA in myotubes. In additional experiments, overexpressing C/EBPβ did not influence atrogin‐1 or MuRF1 expression in myoblasts or myotubes. Taken together, our observations suggest that glucocorticoid‐induced muscle wasting is at least in part regulated by C/EBPβ. Increased C/EBPβ expression alone, however, is not sufficient to upregulate atrogin‐1 and MuRF1 expression. J. Cell. Biochem. 112: 1737–1748, 2011. © 2011 Wiley‐Liss, Inc.
ISSN:0730-2312
1097-4644
DOI:10.1002/jcb.23093